- Home
- ONC vs FIS Comparison
ONC vs FIS Comparison
Compare ONC & FIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | FIS |
|---|---|---|
| Founded | 2010 | 1968 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 34.0B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | ONC | FIS |
|---|---|---|
| Price | $268.53 | $38.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $385.10 | $72.23 |
| AVG Volume (30 Days) | 257.0K | ★ 5.3M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.58 |
| Revenue | N/A | ★ $10,677,000,000.00 |
| Revenue This Year | $723.76 | $30.41 |
| Revenue Next Year | $15.04 | $4.76 |
| P/E Ratio | $614.06 | ★ $8.44 |
| Revenue Growth | N/A | ★ 5.43 |
| 52 Week Low | $239.25 | $37.91 |
| 52 Week High | $385.22 | $82.74 |
Technical Indicators
Market Signals| Indicator | ONC | FIS |
|---|---|---|
| Relative Strength Index (RSI) | 39.72 | 34.47 |
| Support Level | $253.95 | N/A |
| Resistance Level | $323.73 | $68.08 |
| Average True Range (ATR) | 7.22 | 1.38 |
| MACD | -0.37 | -0.06 |
| Stochastic Oscillator | 44.16 | 7.77 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About FIS Fidelity National Information Services Inc.
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.